Credo Technology Group Holding Ltd
CRDO Nasdaq Semiconductors & Related Devices Financials FY2020βFY2026
What Credo Technology Group Holding Ltd does
No business description yet.
- Legal name
- Credo Technology Group Holding Ltd
- Fiscal year ends
- May 2, 2026
- Latest annual report
- 10-K Β· Jun 15, 2026
- Accession Β· CIK
- 0001628280-26-043303
0001807794
Revenue and margins
Credo Technology Group Holding Ltd had $1.3B of revenue in fiscal 2026, up 205.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $407M in fiscal 2026, 30.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Credo Technology Group Holding Ltd returned β to shareholders in fiscal 2026. The diluted share count rose 3.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Credo Technology Group Holding Ltd can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $259M | $218M | $410M | $431M | $1.4B |
| Current ratio | 12.5x | 10.6x | 11.9x | 6.6x | 10.2x |
| Quick ratio | 11.5x | 9.1x | 11.3x | 5.8x | 8.9x |
| Total assets | $376M | $397M | $602M | $809M | $2.3B |
| Total liabilities | $41.5M | $49.7M | $61.7M | $128M | $232M |
| Shareholders' equity | $334M | $348M | $540M | $682M | $2.1B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 2 / 8 | 2 / 8 | 4 / 8 | 6 / 8 | 6 / 8 |
| Accruals ratio | β | 9.6% | 3.3% | 2.1% | β12.2% | β1.8% | 0.5% |
| Altman Z'' | β | β1.73 | 12.61 | 11.02 | 13.33 | 10.49 | 16.35 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $53.8M | $58.7M | $106M | $184M | $193M | $437M | $1.3B |
| Gross profit | $46.1M | $38.3M | $64.0M | $106M | $119M | $283M | $908M |
| Research and development | $27.6M | $34.8M | $47.9M | $76.8M | $96.3M | $147M | $279M |
| Operating income | $2.1M | β$25.2M | β$22.0M | β$21.2M | β$37.1M | $37.1M | $445M |
| Pretax income | $2.1M | β$25.3M | β$22.2M | β$17.9M | β$22.7M | $54.9M | $475M |
| Income tax | $0.8M | $2.2M | β$0.0M | β$1.4M | $5.6M | $2.7M | $3.2M |
| Net income | $1.3M | β$27.5M | β$22.2M | β$16.5M | β$28.4M | $52.2M | $472M |
| Net income to common | $0.0M | β$27.5M | β$22.2M | β | β | β | β |
| Diluted EPS | $0.00 | β$0.40 | β$0.25 | β$0.11 | β$0.18 | $0.29 | $2.51 |
| Diluted shares | 0.07B | 0.07B | 0.09B | 0.15B | 0.16B | 0.18B | 0.19B |
| Cash flow | |||||||
| Cash from operations | β$10.3M | β$42.4M | β$30.8M | β$24.6M | $32.7M | $65.1M | $464M |
| Capital expenditure | $8.8M | $6.1M | $17.6M | $21.7M | $15.7M | $36.1M | $57.3M |
| Free cash flow | β$19.1M | β$48.4M | β$48.4M | β$46.3M | $17.1M | $29.0M | $407M |
| Depreciation and amortization | $1.8M | $2.2M | $4.8M | $9.5M | $13.8M | $21.9M | $34.6M |
| Stock-based compensation | $1.2M | $2.6M | $9.2M | $23.5M | $39.0M | $77.4M | $183M |
| Acquisitions | β | β | β | β | $0.0M | $0.0M | $113M |
| Share buybacks | $0.0M | $22.9M | $0.0M | $0.0M | β | β | β |
| Dividends and buybacks | $0.0M | $22.9M | $0.0M | $0.0M | β | β | β |
| Balance sheet | |||||||
| Cash and short-term investments | $73.9M | $104M | $259M | $218M | $410M | $431M | $1.4B |
| Current assets | β | $138M | $332M | $328M | $530M | $714M | $2.0B |
| Current liabilities | β | $12.5M | $26.5M | $31.0M | $44.6M | $108M | $197M |
| Inventory | β | $7.1M | $27.3M | $46.0M | $25.9M | $90.0M | $251M |
| Property and equipment, net | β | $14.2M | $21.8M | $40.2M | $43.7M | $63.6M | $102M |
| Goodwill | β | β | β | β | β | $0.0M | $92.8M |
| Intangible assets | β | β | β | β | β | $0.0M | $29.3M |
| Total assets | β | $155M | $376M | $397M | $602M | $809M | $2.3B |
| Total liabilities | β | $13.0M | $41.5M | $49.7M | $61.7M | $128M | $232M |
| Shareholders' equity | β$9.4M | β$55.4M | $334M | $348M | $540M | $682M | $2.1B |
| Margins | |||||||
| Gross margin | 85.6% | 65.2% | 60.1% | 57.7% | 61.9% | 64.8% | 68.0% |
| Operating margin | 3.8% | β43.0% | β20.6% | β11.5% | β19.2% | 8.5% | 33.3% |
| EBITDA margin | 7.2% | β39.2% | β16.1% | β6.4% | β12.1% | 13.5% | 35.9% |
| Net margin | 2.5% | β46.9% | β20.8% | β9.0% | β14.7% | 11.9% | 35.4% |
| FCF margin | β35.5% | β82.5% | β45.5% | β25.2% | 8.9% | 6.6% | 30.5% |
| Returns | |||||||
| Return on capital employed | β | β17.7% | β6.3% | β5.8% | β6.6% | 5.3% | 21.2% |
| Return on equity | β | β | β15.9% | β4.9% | β6.4% | 8.5% | 34.4% |
| Return on assets | β | β17.7% | β8.3% | β4.3% | β5.7% | 7.4% | 30.4% |
| Return on tangible equity | β | β | β6.6% | β4.8% | β5.3% | 7.7% | 24.3% |
| Growth | |||||||
| Revenue growth | β | 9.0% | 81.4% | 73.0% | 4.8% | 126.3% | 205.7% |
| Net income growth | β | β2,170.1% | β | β | β | β | 805.0% |
| EPS growth | β | β | β | β | β | β | 765.5% |
| FCF growth | β | β | β | β | β | 69.9% | 1,302.4% |
| Share count change | β | β3.7% | 27.9% | 65.8% | 5.8% | 16.8% | 3.9% |
| Financial health | |||||||
| Current ratio | β | 11.0x | 12.5x | 10.6x | 11.9x | 6.6x | 10.2x |
| Quick ratio | β | 10.4x | 11.5x | 9.1x | 11.3x | 5.8x | 8.9x |
| Capital allocation | |||||||
| Capex / revenue | 16.4% | 10.3% | 16.5% | 11.8% | 8.1% | 8.3% | 4.3% |
| Stock comp / revenue | 2.3% | 4.4% | 8.6% | 12.8% | 20.2% | 17.7% | 13.7% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 2.0 | 2.0 | 4.0 | 6.0 | 6.0 |
| Altman Z'' | β | β1.7 | 12.6 | 11.0 | 13.3 | 10.5 | 16.3 |
| Accruals ratio | β | 9.6% | 3.3% | 2.1% | β12.2% | β1.8% | 0.5% |
Source: SEC EDGAR XBRL filings (CIK 0001807794). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.